November 17, 2025 · Form 4 insider transaction
Scott Randal W. bought 10,000 shares of BridgeBio Pharma, Inc. at $16.75 per share, a transaction worth $167.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.